Barrett's oesophagus

被引:281
作者
Shaheen, Nicholas J. [1 ]
Richter, Joel E. [2 ]
机构
[1] Univ N Carolina, Sch Med, Ctr Esophageal Dis & Swallowing, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
[2] Temple Univ, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19122 USA
关键词
HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; SPECIALIZED INTESTINAL METAPLASIA; ENDOSCOPIC MUCOSAL RESECTION; BAND IMAGING ENDOSCOPY; BODY-MASS INDEX; TERM-FOLLOW-UP; PHOTODYNAMIC THERAPY; CAPSULE ENDOSCOPY; HELICOBACTER-PYLORI;
D O I
10.1016/S0140-6736(09)60487-6
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Barrett's oesophagus is a metaplastic change of the lining of the oesophagus, such that the normal squamous epithelium is replaced by specialised or intestinalised columnar epithelium. The disorder seems to be a complication of chronic gastro-oesophageal reflux disease, although asymptomatic individuals might also be affected, and it is a risk factor for the development of oesophageal adenocarcinoma, a cancer with rapidly increasing incidence in developed societies. We review the presentation, epidemiology, and risk factors for this condition. We discuss the molecular changes necessary for the development of Barrett's oesophagus and its progression to cancer, and new strides in both the endoscopic detection of the lesion and the treatment of dysplastic disease. Also, we assess the effectiveness of efforts to screen patients at risk of Barrett's oesophagus, and whether such efforts avert cancer death. We conclude with a discussion of future directions for research, focusing on treatment of early neoplasia, and modifications of current practices to show our evolving understanding of this condition.
引用
收藏
页码:850 / 861
页数:12
相关论文
共 137 条
[1]
Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery [J].
Ackroyd, R ;
Tam, W ;
Schoeman, M ;
Devitt, PG ;
Watson, DI .
GASTROINTESTINAL ENDOSCOPY, 2004, 59 (01) :1-7
[2]
Ackroyd R, 2003, ENDOSCOPY, V35, P496
[3]
Argon Beam Plasma Coagulation as Therapy for High-Grade Dysplasia in Barrett's Esophagus [J].
Attwood, Stephen E. A. ;
Lewis, Christopher J. ;
Caplin, Scott ;
Hemming, Karla ;
Armstrong, Gordon .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (04) :258-263
[4]
Hiatal hernia and acid reflux frequency predict presence and length of Barrett's Esophagus [J].
Avidan, B ;
Sonnenberg, A ;
Schnell, TG ;
Sontag, SJ .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (02) :256-264
[5]
Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma [J].
Avidan, B ;
Sonnenberg, A ;
Schnell, TG ;
Sontag, SJ .
GASTROENTEROLOGY, 2001, 121 (06) :1281-1285
[6]
RESTORATION OF SQUAMOUS MUCOSA AFTER ABLATION OF BARRETT ESOPHAGEAL EPITHELIUM [J].
BERENSON, MM ;
JOHNSON, TD ;
MARKOWITZ, NR ;
BUCHI, KN ;
SAMOWITZ, WS .
GASTROENTEROLOGY, 1993, 104 (06) :1686-1691
[7]
Hospital volume and surgical mortality in the United States. [J].
Birkmeyer, JD ;
Siewers, AE ;
Finlayson, EVA ;
Stukel, TA ;
Lucas, FL ;
Batista, I ;
Welch, HG ;
Wennberg, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137
[8]
BREMNER CG, 1970, SURGERY, V68, P209
[9]
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma [J].
Buttar, NS ;
Wang, KK ;
Sebo, TJ ;
Riehle, DM ;
Krishnadath, KK ;
Lutzke, LS ;
Anderson, MA ;
Petterson, TM ;
Burgart, LJ .
GASTROENTEROLOGY, 2001, 120 (07) :1630-1639
[10]
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus [J].
Buttar, NS ;
Wang, KK ;
Leontovich, O ;
Westcott, JY ;
Pacifico, RJ ;
Anderson, MA ;
Krishnadath, KK ;
Lutzke, LS ;
Burgart, LJ .
GASTROENTEROLOGY, 2002, 122 (04) :1101-1112